Company / Assets per Share
Oruka Therapeutics, Inc. Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.00
FY2024
5-year range
$0.00 / $31.64
FY2020-FY2024
Trend
-100.0%
vs FY2023
Sector context
#210 of 210
Health Care
What the data says
Among 210 Health Care companies, Oruka Therapeutics, Inc. is in the bottom 0% for assets per share. Assets per Share has declined for 4 consecutive years, from $31.64 in FY2020 to $0.00 in FY2024.
Based on SEC 10-K filings.
0.00 in FY2024 with a 5-year CAGR of -91.2%.
Declined from $2.99 to $0.00 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -97.8%
- 5-Year CAGR
- -91.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 210This company $0.00 Sector average $296.79
▼
-100.0% below sector average
Key checks
Key Insights
- Oruka Therapeutics, Inc.'s assets per share has declined for 4 consecutive years.
- In FY2024, assets per share decreased 100.0% year-over-year.
- Ranks #210 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | -100.0% |
| FY2023 | $2.63 | -12.1% |
| FY2022 | $2.99 | -48.0% |
| FY2021 | $5.75 | -81.8% |
| FY2020 | $31.64 | +186.7% |
| FY2019 | $11.03 | +1803.8% |
| FY2018 | $0.58 | -57.4% |
| FY2017 | $1.36 | -50.0% |
| FY2016 | $2.72 | -79.2% |
| FY2015 | $13.10 | +1173.5% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026